Sutro Biopharma CSO Dr. Trevor Hallam resigns, effective May 31, 2023

SUTRO BIOPHARMA, INC.

Dr. Trevor Hallam resigns as President of Research and Chief Scientific Officer effective May 31, 2023.
Resignation is not due to any disagreement with management or the board.
No successor has been announced.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Trevor Hallam

President of Research and Chief Scientific Officer

STRO · SUTRO BIOPHARMA, INC.

Effective: 2023-05-31
Filed: April 27, 2023, 7:59 PM ET

On April 24, 2023, Dr. Trevor Hallam notified Sutro Biopharma, Inc. (the “ Company ”) that he will resign from his role as President of Research and Chief Scientific Officer of the Company, effective May 31, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Trevor Hallam resigned as President of Research and Chief Scientific Officer at SUTRO BIOPHARMA, INC..

Action: resigned
Role: President of Research and Chief Scientific Officer

Exact text from the filing

On April 24, 2023, Dr. Trevor Hallam notified Sutro Biopharma, Inc. (the “ Company ”) that he will resign from his role as President of Research and Chief Scientific Officer of the Company, effective May 31, 2023.

View on SEC.gov

SUTRO BIOPHARMA, INC. filing history →

Source: SEC EDGAR

accession 0000950170-23-015323

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.